These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 16698846

  • 1. Activity of mecillinam against AmpC beta-lactamase-producing Escherichia coli.
    Brenwald NP, Andrews J, Fraise AP.
    J Antimicrob Chemother; 2006 Jul; 58(1):223-4. PubMed ID: 16698846
    [No Abstract] [Full Text] [Related]

  • 2. Disc methods for detecting AmpC {beta}-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae.
    Brenwald NP, Jevons G, Andrews J, Ang L, Fraise AP.
    J Antimicrob Chemother; 2005 Sep; 56(3):600-1. PubMed ID: 16087656
    [No Abstract] [Full Text] [Related]

  • 3. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS, Blázquez J, Baquero F, Shoichet BK.
    J Med Chem; 1998 Nov 05; 41(23):4577-86. PubMed ID: 9804697
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of mecillinam and amoxicillin/clavulanic acid against strains of Escherichia coli producing TEM-1, Oxa-1 and chromosomal beta-lactamases.
    Marre R, Schulz E.
    Arzneimittelforschung; 1988 Jul 05; 38(7):863-5. PubMed ID: 3061383
    [Abstract] [Full Text] [Related]

  • 5. Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases.
    Sougakoff W, Jarlier V.
    J Antimicrob Chemother; 2000 Sep 05; 46 Suppl 1():9-14; discussion 63-5. PubMed ID: 11051618
    [Abstract] [Full Text] [Related]

  • 6. Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Lampri N, Galani I, Poulakou G, Katsarolis I, Petrikkos G, Giamarellou H, Souli M.
    J Antimicrob Chemother; 2012 Oct 05; 67(10):2424-8. PubMed ID: 22665388
    [Abstract] [Full Text] [Related]

  • 7. Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase.
    Buzzoni V, Blazquez J, Ferrari S, Calò S, Venturelli A, Costi MP.
    Bioorg Med Chem Lett; 2004 Aug 02; 14(15):3979-83. PubMed ID: 15225711
    [Abstract] [Full Text] [Related]

  • 8. Detection of extended-spectrum beta-lactamases by using boronic acid as an AmpC beta-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli.
    Song W, Bae IK, Lee YN, Lee CH, Lee SH, Jeong SH.
    J Clin Microbiol; 2007 Apr 02; 45(4):1180-4. PubMed ID: 17301276
    [Abstract] [Full Text] [Related]

  • 9. Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
    de Sá Del Fiol F, Rocha De Mattos Filho T, Groppo FC.
    Braz J Infect Dis; 2000 Feb 02; 4(1):36-42. PubMed ID: 10788844
    [Abstract] [Full Text] [Related]

  • 10. Synergistic and bactericidal activities of mecillinam, amoxicillin and clavulanic acid combinations against extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in 24-h time-kill experiments.
    Skarp KP, Shams A, Montelin H, Lagerbäck P, Tängdén T.
    Int J Antimicrob Agents; 2019 Jan 02; 53(1):74-79. PubMed ID: 30236958
    [Abstract] [Full Text] [Related]

  • 11. The complexed structure and antimicrobial activity of a non-beta-lactam inhibitor of AmpC beta-lactamase.
    Powers RA, Blázquez J, Weston GS, Morosini MI, Baquero F, Shoichet BK.
    Protein Sci; 1999 Nov 02; 8(11):2330-7. PubMed ID: 10595535
    [Abstract] [Full Text] [Related]

  • 12. AmpC beta-lactamase-mediated cefpodoxime-resistant Escherichia coli isolated from faecal samples of healthy volunteers.
    Kaneko K, Sato Y, Tokunaga SK, Tamaki SK, Okamoto R, Inoue M.
    J Antimicrob Chemother; 2006 Feb 02; 57(2):369-71. PubMed ID: 16338950
    [No Abstract] [Full Text] [Related]

  • 13. Interplay of efflux, impermeability, and AmpC activity contributes to cefuroxime resistance in clinical, non-ESBL-producing isolates of Escherichia coli.
    Källman O, Giske CG, Samuelsen Ø, Wretlind B, Kalin M, Olsson-Liljequist B.
    Microb Drug Resist; 2009 Jun 02; 15(2):91-5. PubMed ID: 19432520
    [Abstract] [Full Text] [Related]

  • 14. Activity of mecillinam against ESBL producers in vitro.
    Thomas K, Weinbren MJ, Warner M, Woodford N, Livermore D.
    J Antimicrob Chemother; 2006 Feb 02; 57(2):367-8. PubMed ID: 16354745
    [No Abstract] [Full Text] [Related]

  • 15. Extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix.
    Mammeri H, Poirel L, Nordmann P.
    J Antimicrob Chemother; 2007 Sep 02; 60(3):490-4. PubMed ID: 17586561
    [Abstract] [Full Text] [Related]

  • 16. Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems using an in vitro model.
    Zhanel GG, Baudry PJ, Tailor F, Cox L, Hoban DJ, Karlowsky JA.
    J Antimicrob Chemother; 2009 Oct 02; 64(4):824-8. PubMed ID: 19643776
    [Abstract] [Full Text] [Related]

  • 17. Optimizing cell permeation of an antibiotic resistance inhibitor for improved efficacy.
    Venturelli A, Tondi D, Cancian L, Morandi F, Cannazza G, Segatore B, Prati F, Amicosante G, Shoichet BK, Costi MP.
    J Med Chem; 2007 Nov 15; 50(23):5644-54. PubMed ID: 17956081
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic utility of boronic acid inhibition with different cephalosporins against Escherichia coli producing AmpC β-lactamases.
    Upadhyay S, Sen MR, Bhattacharjee A.
    J Med Microbiol; 2011 May 15; 60(Pt 5):691-3. PubMed ID: 21292860
    [No Abstract] [Full Text] [Related]

  • 19. Escherichia coli producing CMY-2 β-lactamase in bovine mastitis milk.
    Endimiani A, Bertschy I, Perreten V.
    J Food Prot; 2012 Jan 15; 75(1):137-8. PubMed ID: 22221366
    [Abstract] [Full Text] [Related]

  • 20. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
    Tan TY, Ng SY, Teo L, Koh Y, Teok CH.
    J Clin Pathol; 2008 May 15; 61(5):642-4. PubMed ID: 18057079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.